Type 2 Diabetes
Showing NaN - NaN of 80
Type 2 Diabetes, High Blood Pressure Trial in Dallas (Polypill)
Not yet recruiting
- Type 2 Diabetes
- High Blood Pressure
-
Dallas, TexasUT Southwestern Medical Center
Nov 21, 2023
Type 2 Diabetes, Obesity, Overweight Trial in Worldwide (Retatrutide, Placebo)
Not yet recruiting
- Type 2 Diabetes
- +3 more
- Retatrutide
- Placebo
-
Los Angeles, California
- +91 more
Jul 10, 2023
Type 2 Diabetes, Obesity, Overweight or Obesity Trial in Worldwide (Orforglipron, Insulin Glargine)
Recruiting
- Type 2 Diabetes
- +5 more
- Orforglipron
- Insulin Glargine
-
Muscle Shoals, Alabama
- +320 more
Apr 12, 2023
Type 2 Diabetes Trial in Worldwide (LY3209590, Insulin Degludec)
Active, not recruiting
- Type 2 Diabetes
- LY3209590
- Insulin Degludec
-
Little Rock, Arkansas
- +129 more
Jan 19, 2023
Diabetes, Type 2 Diabetes Trial in Worldwide (LY3209590, Insulin Degludec)
Recruiting
- Diabetes
- Type 2 Diabetes
- LY3209590
- Insulin Degludec
-
Escondido, California
- +128 more
Jan 18, 2023
Hypertension, Type 2 Diabetes Trial in Dallas (Home visit)
Recruiting
- Hypertension
- Type 2 Diabetes
- Home visit
-
Dallas, TexasUT Southwestern Medical Center
Aug 23, 2022
Type 2 Diabetes, Type 2 Diabetes Treated With Insulin Trial in Worldwide (LY3209590, Insulin Lispro (U100), Insulin Glargine
Not yet recruiting
- Type 2 Diabetes
- Type 2 Diabetes Treated With Insulin
- LY3209590
- +2 more
-
Hamden, Connecticut
- +82 more
Aug 8, 2022
Type 2 Diabetes Trial in Worldwide (Tirzepatide, Antihyperglycemic medication)
Not yet recruiting
- Type 2 Diabetes
- Tirzepatide
- Antihyperglycemic medication
-
Birmingham, Alabama
- +96 more
Aug 8, 2022
Type 2 Diabetes, Overweight, Obesity Trial in Worldwide (Tirzepatide, Placebo)
Active, not recruiting
- Type 2 Diabetes
- +2 more
- Tirzepatide
- Placebo
-
Birmingham, Alabama
- +74 more
Apr 18, 2022
Type 2 Diabetes, Comparative Effectiveness of Glycemia-lowering Medications Trial in United States (Sulfonylurea (glimepiride),
Completed
- Type 2 Diabetes
- Comparative Effectiveness of Glycemia-lowering Medications
- Sulfonylurea (glimepiride)
- +3 more
-
Birmingham, Alabama
- +35 more
Apr 13, 2022
Type 2 Diabetes Trial in Worldwide (Mylan's insulin glargine, LantusĀ®)
Type 2 Diabetes Trial in Worldwide (Tirzepatide, Semaglutide)
Completed
- Type 2 Diabetes
-
Birmingham, Alabama
- +126 more
Jan 21, 2022
Type 2 Diabetes, MDD Trial in Dallas (Diabetes and depression intervention, Diabetes intervention)
Completed
- Type 2 Diabetes
- Major Depressive Disorder
- Diabetes and depression intervention
- Diabetes intervention
-
Dallas, TexasFamily and Community Medicine Clinic, University of Texas Southw
Sep 1, 2020
Type 2 Diabetes Trial in United States (Mesenchymal Precursor Cells (MPCs))
Completed
- Type 2 Diabetes
- Mesenchymal Precursor Cells (MPCs)
-
Garden Grove, California
- +17 more
Jun 1, 2020
Chronic Kidney Disease, Diabetes, Hypertension Trial in Farmington, Arlington, Dallas (Collaborative Model of Primary care and
Completed
- Chronic Kidney Disease
- +4 more
- Collaborative Model of Primary care and Subspecialty care
-
Farmington, Connecticut
- +3 more
Oct 10, 2019